{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:29:58Z","timestamp":1762993798528,"version":"3.45.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004316","name":"International Business Machines Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL139731"],"award-info":[{"award-number":["1R01HL139731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18SFRN34250007"],"award-info":[{"award-number":["18SFRN34250007"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.hroo.2021.10.009","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T03:06:27Z","timestamp":1639710387000},"page":"819-831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PB","title":["Ventricular arrhythmia management in patients with genetic cardiomyopathies"],"prefix":"10.1016","volume":"2","author":[{"given":"Zain I.","family":"Sharif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Lubitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2021.10.009_bib1","first-page":"e272","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/europace\/eut272","article-title":"Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"15","author":"Priori","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.10.009_bib3","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib4","first-page":"e533","article-title":"2020 AHA\/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib5","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jchf.2018.02.010","article-title":"Hypertrophic cardiomyopathy: clinical update","volume":"6","author":"Geske","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hroo.2021.10.009_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCULATIONAHA.120.051968","article-title":"Gaps in evidence for risk stratification for sudden cardiac death in hypertrophic cardiomyopathy","volume":"143","author":"Pelliccia","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib9","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/hrt.2003.014969","article-title":"Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography","volume":"90","author":"Moon","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.hroo.2021.10.009_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006309","article-title":"Discrepant measurements of maximal left ventricular wall thickness between cardiac magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathy","volume":"10","author":"Hindieh","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2021.10.009_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.amjcard.2016.11.010","article-title":"Comparison of maximal wall thickness in hypertrophic cardiomyopathy differs between magnetic resonance imaging and transthoracic echocardiography","volume":"119","author":"Bois","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/ehjci\/jeaa423","article-title":"Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study","volume":"22","author":"Greulich","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2021.10.009_bib15","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.hroo.2021.10.009_bib16","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.jcmg.2020.06.009","article-title":"LGE for risk stratification in primary prevention in children with HCM","volume":"13","author":"Petryka-Mazurkiewicz","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2021.10.009_bib17","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jacc.2019.02.065","article-title":"Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias","volume":"73","author":"Ariga","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005372","article-title":"How to image hypertrophic cardiomyopathy","volume":"10","author":"Maron","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2021.10.009_bib19","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function","volume":"72","author":"Mentias","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib22","first-page":"1791","article-title":"Variable and limited predictive value of the European Society of Cardiology hypertrophic cardiomyopathy sudden-death risk model: a meta-analysis","volume":"35","author":"Wang","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib23","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1136\/heartjnl-2019-315160","article-title":"Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians","volume":"105","author":"Choi","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.hroo.2021.10.009_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","article-title":"Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management","volume":"69","author":"Rowin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib26","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRE)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ahj.2015.05.013","article-title":"Hypertrophic Cardiomyopathy Registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy","volume":"170","author":"Kramer","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib28","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(99)00056-X","article-title":"Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy","volume":"33","author":"Elliott","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1540-8167.2009.01716.x","article-title":"Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up","volume":"21","author":"Syska","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCHEARTFAILURE.112.969626","article-title":"Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Schinkel","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hroo.2021.10.009_bib31","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy","volume":"61","author":"Maron","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006937","volume":"6","author":"Peterson","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2021.10.009_bib33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jchf.2014.05.015","article-title":"Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study","volume":"2","author":"Kolb","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hroo.2021.10.009_bib34","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib35","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","article-title":"Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)","volume":"99","author":"Maron","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib36","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/oxfordjournals.eurheartj.a015435","article-title":"Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group","volume":"18","author":"Kappenberger","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0735-1097(96)00473-1","article-title":"Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial","volume":"29","author":"Nishimura","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib38","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.amjcard.2006.01.040","article-title":"Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age","volume":"97","author":"Topilski","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib39","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib40","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/CIRCEP.110.961243","article-title":"Minimizing inappropriate or \u201cunnecessary\u201d implantable cardioverter-defibrillator shocks: appropriate programming","volume":"4","author":"Koneru","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib41","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/CIRCEP.113.000744","article-title":"Performance of lead integrity alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads","volume":"6","author":"Ellenbogen","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jce.13194","article-title":"Ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy and defibrillators: triggers, treatment, and implications","volume":"28","author":"Link","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/hrt.53.4.412","article-title":"Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia","volume":"53","author":"McKenna","year":"1985","journal-title":"Br Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib44","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/hrt.2006.099416","article-title":"Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy","volume":"93","author":"Melacini","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.hroo.2021.10.009_bib45","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.hrthm.2010.05.022","article-title":"Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility","volume":"7","author":"Santangeli","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacep.2017.12.020","article-title":"Radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy and apical aneurysm","volume":"4","author":"Igarashi","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1540-8167.2010.01875.x","article-title":"Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy","volume":"22","author":"Inada","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCEP.110.957290","article-title":"Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy","volume":"4","author":"Dukkipati","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.hrthm.2017.09.006","article-title":"Cardiac sympathectomy for the management of ventricular arrhythmias refractory to catheter ablation","volume":"15","author":"Richardson","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hrcr.2019.10.003","article-title":"Successful bilateral thoracoscopic sympathectomy for recurrent ventricular arrhythmia in a pediatric patient with hypertrophic cardiomyopathy","volume":"6","author":"Price","year":"2020","journal-title":"HeartRhythm Case Rep"},{"key":"10.1016\/j.hroo.2021.10.009_bib51","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia. Proposed modification of the Task Force Criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib52","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0735-1097(97)00332-X","article-title":"Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a multicenter study","volume":"30","author":"Corrado","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib53","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.jacc.2006.07.045","article-title":"Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype","volume":"48","author":"Sen-Chowdhry","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib54","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.104.532234","article-title":"Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy","volume":"112","author":"Norman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib55","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib56","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"Van der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2021.10.009_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2019.09.048","article-title":"Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype.","volume":"307","author":"Hall","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib58","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/01.CIR.65.2.384","article-title":"Right ventricular dysplasia: a report of 24 adult cases","volume":"65","author":"Marcus","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hroo.2021.10.009_bib60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198801213180301","article-title":"Right ventricular cardiomyopathy and sudden death in young people","volume":"318","author":"Thiene","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.10.009_bib61","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.109.853143","article-title":"Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER)","volume":"120","author":"Krahm","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib62","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCEP.113.001376","article-title":"Pathogeneses of sudden cardiac death in national collegiate athletic association athletes","volume":"7","author":"Harmon","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib63","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006470","article-title":"Sudden cardiac death in the young: incidence, trends, and risk factors in a nationwide study","volume":"13","author":"Ha","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hroo.2021.10.009_bib64","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/eurheartj\/ehx011","article-title":"Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy\/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome","volume":"38","author":"Akdis","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib65","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.hrthm.2005.08.022","article-title":"Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia","volume":"2","author":"Piccini","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib66","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjcard.2012.09.025","article-title":"Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy","volume":"111","author":"Saguner","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib67","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacep.2018.04.017","article-title":"Risk stratification in arrhythmogenic right ventricular cardiomyopathy\/dysplasia without an implantable cardioverter-defibrillator","volume":"4","author":"Maupain","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.10.009_bib69","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/eurheartj\/ehaa141","article-title":"The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy","volume":"41","author":"James","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib70","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/europace\/euu128","article-title":"Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype","volume":"16","author":"Lopez-Ayala","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.10.009_bib71","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib72","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2009.11.020","article-title":"Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy","volume":"55","author":"Xu","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib73","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/CIRCULATIONAHA.110.988287","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy: pathogenic desmosome mutations in index patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia\/cardiomyopathy genotype-phenotype follow-up study","volume":"123","author":"Cox","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib74","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hroo.2021.10.009_bib75","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/europace\/euq104","article-title":"Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: spectrum of mutations and clinical impact in practice","volume":"12","author":"Fressart","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.10.009_bib76","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib77","article-title":"Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy","volume":"14","author":"Cadrin-Tourigny","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib78","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.jacc.2020.04.023","article-title":"Prognostic value of magnetic resonance phenotype in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"75","author":"Aquaro","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib79","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/jce.12222","article-title":"Mutation-positive arrhythmogenic right ventricular dysplasia\/cardiomyopathy: the triangle of dysplasia displaced","volume":"24","author":"Te Riele","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib80","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an International Task Force Consensus Statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1009714718034","article-title":"Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators","volume":"1","author":"Link","year":"1997","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib82","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.10.009_bib83","doi-asserted-by":"crossref","first-page":"204","DOI":"10.14740\/cr734w","article-title":"Appropriate and inappropriate implantable cardioverter defibrillator therapies in arrhythmogenic right ventricular cardiomyopathy\/dysplasia patients","volume":"9","author":"Al-Ghamdi","year":"2018","journal-title":"Cardiol Res"},{"key":"10.1016\/j.hroo.2021.10.009_bib84","first-page":"e273","volume":"132","author":"Marron","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib85","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.jacc.2016.09.951","article-title":"Arrhythmogenic right ventricular cardiomyopathy: clinical course and predictors of arrhythmic risk","volume":"68","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib86","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1016\/j.hrthm.2019.03.002","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias","volume":"17","author":"Cronin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib87","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacep.2020.04.029","article-title":"RV tissue heterogeneity on CT: a novel tool to identify the VT substrate in ARVC","volume":"6","author":"Venlet","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib88","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib89","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.hrthm.2014.12.018","article-title":"Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"12","author":"Philips","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib90","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","article-title":"Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"120","author":"Garcia","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib91","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.hrthm.2021.04.028","article-title":"Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: insights from the Johns Hopkins ARVC Program","volume":"18","author":"Daimee","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib92","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.hrthm.2019.01.019","article-title":"Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy","volume":"16","author":"Assis","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib93","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/eurjhf\/hft013","article-title":"Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience","volume":"15","author":"van Spaendonck-Zwarts","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2021.10.009_bib94","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/01.cir.0000437913.98912.1d","article-title":"Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association","volume":"128","author":"Ganesh","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib95","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib96","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","article-title":"Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation","volume":"39","author":"Hasselberg","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib97","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib98","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jacep.2020.04.025","article-title":"Prevalence and prognostic impact of pathogenic variants in patients with dilated cardiomyopathy referred for ventricular tachycardia ablation","volume":"6","author":"Elbert","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib99","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib100","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/europace\/euaa171","article-title":"Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study","volume":"22","author":"Peretto","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.10.009_bib101","unstructured":"Celeghin R, Cipriani A, Bariani R, et\u00a0al. Filamin C variant-associated cardiomyopathy: a pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death. Heart Rhythm 2021 Oct 1;S1547-5271(21)02205-0."},{"key":"10.1016\/j.hroo.2021.10.009_bib102","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41436-021-01255-1","article-title":"Clinical impact of re-evaluating genes and variants implicated in dilated cardiomyopathy","volume":"23","author":"Stroekes","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.hroo.2021.10.009_bib103","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib104","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib105","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.hrthm.2013.06.020","article-title":"Implantable cardioverter defibrillators in lamin A\/C mutation carriers with cardiac conduction disorders","volume":"10","author":"Anselme","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib106","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.hrthm.2020.05.023","article-title":"Ventricular tachycardia in cardiolaminopathy: characteristics and considerations for device programming","volume":"17","author":"Sidhu","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib107","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study","volume":"129","author":"Dinov","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib108","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004357","article-title":"Multicenter experience with catheter ablation for ventricular tachycardia in lamin A\/C cardiomyopathy","volume":"9","author":"Kumar","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1532-429X-13-30","article-title":"Late gadolinium enhanced cardiovascular magnetic resonance of lamin A\/C gene mutation related dilated cardiomyopathy","volume":"13","author":"Holmstrom","year":"2011","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hroo.2021.10.009_bib110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCEP.114.001568","article-title":"Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types","volume":"7","author":"Oloriz","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib111","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCEP.113.000537","article-title":"Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy","volume":"6","author":"Piers","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib112","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2005.03.045","article-title":"Left ventricular noncompaction: insights from cardiovascular magnetic resonance imaging","volume":"46","author":"Petersen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib113","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.19102\/icrm.2017.080701","article-title":"Spectrum of cardiac arrhythmias in isolated ventricular non-compaction","volume":"8","author":"Tumolo","year":"2017","journal-title":"J Innov Card Rhythm Manag"},{"key":"10.1016\/j.hroo.2021.10.009_bib114","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(14)61282-4","article-title":"Left ventricular non-compaction cardiomyopathy","volume":"386","author":"Towbin","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.hroo.2021.10.009_bib115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0735-1097(99)00170-9","article-title":"Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background","volume":"34","author":"Ichida","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib116","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacc.2014.06.1155","article-title":"The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel","volume":"64","author":"Schweizer","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib117","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.amjcard.2017.07.103","article-title":"Complications associated with implantable cardioverter defibrillators in adults with congenital heart disease or left ventricular noncompaction cardiomyopathy (From the NCDR((R)) Implantable Cardioverter-Defibrillator Registry)","volume":"120","author":"Gleva","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib118","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cardfail.2011.05.002","article-title":"Isolated noncompaction of ventricular myocardium in adults: a systematic overview","volume":"17","author":"Bhatia","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.hroo.2021.10.009_bib119","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.CIR.0000100664.10777.B8","article-title":"Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy","volume":"108","author":"Pignatelli","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib120","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1253\/circj.CJ-16-1114","article-title":"Long-term prognosis of patients with left ventricular noncompaction\u2014comparison between infantile and juvenile types","volume":"81","author":"Wang","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.hroo.2021.10.009_bib121","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCULATIONAHA.117.032262","article-title":"Long-term outcomes of childhood left ventricular noncompaction cardiomyopathy: results from a national population-based study. National Australian Childhood Cardiomyopathy Study","volume":"138","author":"Shi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib122","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/jcm9030785","article-title":"Left ventricular noncompaction and congenital heart disease increases the risk of congestive heart failure","volume":"9","author":"Hirono","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.hroo.2021.10.009_bib123","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s12887-020-02312-5","article-title":"Do children with left ventricular noncompaction and a noncompaction-to-compaction ratio <2 have a better prognosis?","volume":"20","author":"Gan","year":"2020","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.hroo.2021.10.009_bib124","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00246-010-9868-5","article-title":"Left-ventricular noncompaction in a pediatric population: predictors of survival","volume":"32","author":"Zuckerman","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib125","first-page":"A14391","article-title":"Assessing the accuracy of the Petersen criteria for left ventricular non-compaction with a novel thresholding technique: long term clinical follow up. Abstract 14391","volume":"140","author":"Femia","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib126","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009712","article-title":"Prognostic significance of left ventricular noncompaction: systematic review and meta-analysis of observational studies","volume":"13","author":"Aung","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2021.10.009_bib127","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/jcm10061232","article-title":"Left ventricular noncompaction\u2014a systematic review of risk factors in the pediatric population","volume":"10","author":"Luczak-Wo\u017aniak","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.hroo.2021.10.009_bib128","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1007\/s00330-021-07875-0","article-title":"The prognostic role of CMR using global planimetric criteria in patients with excessive left ventricular trabeculation","volume":"31","author":"Macaione","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib129","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ehf2.12795","article-title":"Biventricular imaging markers to predict outcomes in non-compaction cardiomyopathy: a machine learning study","volume":"7","author":"Rocon","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hroo.2021.10.009_bib130","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012993","article-title":"Systematic review of genotype-phenotype correlations in noncompaction cardiomyopathy","volume":"8","author":"van Waning","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2021.10.009_bib131","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jacc.2017.12.019","article-title":"Genetics, clinical features, and long-term outcome of noncompaction cardiomyopathy","volume":"71","author":"van Waning","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib132","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.echo.2009.09.003","article-title":"Cardiac segmental analysis in left ventricular noncompaction: Experience in a pediatric population","volume":"23","author":"Punn","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.hroo.2021.10.009_bib133","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2008.04.014","article-title":"ACC\/AHA\/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities","volume":"5","author":"Epstein","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib134","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.hrthm.2016.11.014","article-title":"Ventricular arrhythmias associated with left ventricular noncompaction: electrophysiologic characteristics, mapping, and ablation","volume":"14","author":"Muser","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.hrthm.2020.12.014","article-title":"Catheter ablation of ventricular arrhythmias in left ventricular noncompaction cardiomyopathy","volume":"18","author":"Mu\u00f1oz","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib136","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jocs.12489","article-title":"Congenital heart surgery in patients with ventricular noncompaction","volume":"30","author":"Yu","year":"2015","journal-title":"J Card Surg"},{"key":"10.1016\/j.hroo.2021.10.009_bib137","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.hrthm.2005.01.005","article-title":"Brugada syndrome: report of the Second Consensus Conference","volume":"2","author":"Antzelevitch","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib138","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/eurheartj\/ehp252","article-title":"Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities","volume":"30","author":"Catalano","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib139","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib140","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","article-title":"Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome","volume":"66","author":"Nademanee","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib141","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jacc.2021.08.010","article-title":"Biventricular myocardial fibrosis and sudden death in patients with Brugada syndrome","volume":"78","author":"Miles","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib142","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/hc1102.105288","article-title":"Natural history of Brugada syndrome: insights for risk stratification and management","volume":"105","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib143","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/pace.13587","article-title":"Prevalence of spontaneous type I ECG pattern, syncope, and other risk markers in sudden cardiac arrest survivors with Brugada syndrome","volume":"42","author":"Leong","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib144","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00392-009-0075-4","article-title":"Prevention of inappropriate ICD shocks in patients with Brugada syndrome","volume":"99","author":"Veltmann","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib146","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.113.001941","article-title":"Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study\u2014part 2","volume":"128","author":"Sacher","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib147","article-title":"Comparative effectiveness of implantable defibrillators for asymptomatic Brugada syndrome: a decision-analytic model","volume":"10","author":"Kurshid","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2021.10.009_bib148","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1540-8167.2006.00455.x","article-title":"Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis","volume":"17","author":"Gehi","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib149","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.hrthm.2013.10.043","article-title":"Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis","volume":"11","author":"Giustetto","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib150","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/CIRCULATIONAHA.108.770917","article-title":"Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome","volume":"118","author":"Morita","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib151","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk Stratification in Brugada syndrome: results of the PRELUDE (Programmed Electrical stimulation predictive value) registry","volume":"59","author":"Prior","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib152","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.hrthm.2011.09.053","article-title":"Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrogram","volume":"9","author":"Makimoto","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib153","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCULATIONAHA.115.017885","article-title":"Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis","volume":"133","author":"Sroubek","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.10.009_bib154","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jacep.2020.08.032","article-title":"A primary prevention clinical risk score model for patients with Brugada syndrome (BRUGADA-RISK)","volume":"7","author":"Honarbakhsh","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/eurheartj\/ehq381","article-title":"Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach","volume":"32","author":"Delise","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib156","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehx119","article-title":"A score model to predict risk of events in patients with Brugada Syndrome","volume":"38","author":"Sieira","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.10.009_bib157","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hrthm.2014.10.014","article-title":"Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes","volume":"12","author":"Olde Nordkamp","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib158","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/europace\/eux009","article-title":"High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes","volume":"20","author":"Conte","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.10.009_bib159","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/europace\/euz029","article-title":"Spotlight on S-ICD\u2122 therapy: 10 years of clinical experience and innovation","volume":"21","author":"B\u00f6geholz","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.10.009_bib160","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2013.02.077","article-title":"Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries","volume":"61","author":"Viskin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib161","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.007143","article-title":"Efficacy and limitations of quinidine in patients with Brugada syndrome","volume":"12","author":"Mazzanti","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib162","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.hrthm.2017.04.019","article-title":"The QUIDAM study: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk","volume":"14","author":"Andorin","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib163","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib164","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCEP.115.003220","article-title":"Brugada syndrome phenotype elimination by epicardial substrate ablation","volume":"8","author":"Brugada","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.10.009_bib165","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.hrthm.2018.03.019","article-title":"Ablation strategies for the management of symptomatic Brugada syndrome: a systematic review","volume":"15","author":"Fernandes","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.10.009_bib166","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.hrthm.2017.01.006","article-title":"A novel method to enhance phenotype, epicardial functional substrates, and ventricular tachyarrhythmias in Brugada syndrome","volume":"14","author":"Chung","year":"2017","journal-title":"Heart Rhythm"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501821002063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501821002063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:26:02Z","timestamp":1762993562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501821002063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":166,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2666501821002063"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2021.10.009","relation":{},"ISSN":["2666-5018"],"issn-type":[{"type":"print","value":"2666-5018"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ventricular arrhythmia management in patients with genetic cardiomyopathies","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2021.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}